Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Place

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 26, 2011
Endobronchial valve migrationMelanie Jenkins, Paul Vaughan, David Place, et al.
Plos One|February 6, 2014
Toll-like receptor 4 limits transmission of Bordetella bronchisepticaOlivier Rolin, Will Smallridge, Michael Henry, et al.
Cell|March 27, 2018
IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome ActivationRajendra Karki, Ein Lee, David Place, et al.
Clinical and Translational Science|June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteersFei Tang, Rebecca Kunder, Tom Chu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 26, 2011
Endobronchial valve migrationMelanie Jenkins, Paul Vaughan, David Place, et al.
Plos One|February 6, 2014
Toll-like receptor 4 limits transmission of Bordetella bronchisepticaOlivier Rolin, Will Smallridge, Michael Henry, et al.
Cell|March 27, 2018
IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome ActivationRajendra Karki, Ein Lee, David Place, et al.
Clinical and Translational Science|June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteersFei Tang, Rebecca Kunder, Tom Chu, et al.
Pageof 1